Please use this identifier to cite or link to this item:
http://hdl.handle.net/2067/1844
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Timperio, Anna Maria | - |
dc.contributor.author | Gevi, Federica | - |
dc.contributor.author | Grazzini, Giuliano | - |
dc.contributor.author | Vaglio, Stefania | - |
dc.contributor.author | Zolla, Lello | - |
dc.date.accessioned | 2011-04-01T06:53:46Z | - |
dc.date.available | 2011-04-01T06:53:46Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | Timperio, A. M. et al. 2010. Comparison among plasma-derived clotting factor VIII by using monodimensional gel electrophoresis and mass spectrometry. "Blood Transfusion" 8(suppl. 3): s98-s104 | it |
dc.identifier.issn | 1723-2007 | - |
dc.identifier.uri | http://hdl.handle.net/2067/1844 | - |
dc.description | L'articolo è disponibile sul sito dell'editore http://www.bloodtransfusion.it | it |
dc.description.abstract | Background. Deficiency or dysfunction of coagulation factor VIII (FVIII) is the underlying cause of haemophilia A. Haemophilic patients are at present treated with plasma-derived FVIII (pdFVIII) or recombinant FVIII (rFVIII) in order to correct their clotting deficiency. pdFVIII concentrates are exclusively produced from human plasma upon pooling from multiple donors. It is not know whether the presence of excess of other plasma proteins, in addition to von Willebrand factor, could stimulate untoward immune responses in the recipient. Thus, information regarding the presence of contaminants in commercial products is of concern. Materials and Methods. Two commercially available pdFVIII concentrates were characterized through SDS-PAGE and mass spectrometry Emoclot® and Beriate® . Results. The components of two pdFVIII products considered in this study were well identified by mass spectrometry analysis, in both cases we found abundant components coming from blood plasma, and some other contaminants. Only in Beriate® we also found truncated form of pdFVIII. Conclusion. The two pdFVIII examined showed the presence of vWF, Fibrinogen in excess, and other substances that could be considered as contaminants or impurities. | it |
dc.language.iso | en | it |
dc.publisher | Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) | it |
dc.subject | Contaminants | it |
dc.subject | Mass spectrometry | it |
dc.subject | SDS-PAGE | it |
dc.subject | Haemophilia A | it |
dc.subject | Plasma | it |
dc.title | Comparison among plasma-derived clotting Factor VIII by using | it |
dc.type | Article | it |
dc.identifier.doi | 10.2450/2010.016S | it |
dc.identifier.pmid | 20606759 | - |
item.fulltext | With Fulltext | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Collections: | DISA - Archivio della produzione scientifica |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
timperio et al.pdf | 12.14 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
10
9
Last Week
0
0
Last month
0
0
checked on Apr 17, 2024
Page view(s)
180
Last Week
0
0
Last month
4
4
checked on Apr 20, 2024
Download(s)
115
checked on Apr 20, 2024
Google ScholarTM
Check
Altmetric
All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents